Public signalCompany raiseAuto-indexed · Unverified

Ansa Biotechnologies, Inc. raised $45.2M

Ansa Biotechnologies, Inc.· EMERYVILLE, US· Biotechnology· Filed Oct 2, 2025

Ansa Biotechnologies, Inc. reported raising capital. Based in EMERYVILLE, CALIFORNIA, US. First sale reported 2024-06-28. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$45.2M
Confidence90%

On the record

Location
EMERYVILLE, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$45.2M
Target amount
$55.5M
Filing date
Oct 2, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Sources & provenance

Operating company sold 45,199,665 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Oct 2, 2025. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnology$10M – $100MCompany Raise

Are you associated with Ansa Biotechnologies, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record